This prospective, single-center, parallel-group, assessor-blinded randomized controlled trial will include 120 voluntary male participants who have had complaints of urinary frequency for at least 3 months and meet the inclusion criteria. Participants will be randomly allocated into two groups (Group 1: Bladder Training + Pelvic Floor Muscle Training; Group 2: Bladder Training Alone). Assessments will be repeated at baseline, at week 4, and at week 8. The primary outcome measure will be 3-day bladder diary data (24-hour voiding frequency); secondary outcomes will include the OAB-V8, ICIQ-OAB, and PGI-I scales, as well as transabdominal ultrasonographic measurements of bladder neck elevation (strength and endurance) and PVR.
Male sex
Age 18-65 years
Complaint of urinary frequency persisting for at least 3 months
On a 3-day bladder diary: ≥8 voids per 24 hours
Active urinary tract infection
Prostate cancer
Prostate surgery within the last 12 months
Parkinson's disease, Multiple sclerosis (MS), Stroke, Spinal cord injury
Parallel
Bladder training plus pelvic floor muscle training
Other interventionBladder training includes strategies for suppressing urgency, gradually extending the intervals between voiding, managing fluid intake, and reducing caffeine consumption. The pelvic floor muscle training component involves three types of contractions: fast contractions (10 repetitions, 3 sets), maximal sustained contractions (10 repetitions, held for 10 seconds each), and functional contractions integrated into daily activities to improve real-life muscle control.
Bladder Training
Other interventionBladder training includes strategies for suppressing urgency, gradually extending the intervals between voiding, managing fluid intake, and reducing caffeine consumption
Pelvic floor muscle strength as assessed by ultrasound
Click on the lead sponsor to view all of their trials.
Bingol University
Lead sponsor
Istanbul Rumeli University
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
